Thermo Fisher ScientificBSP:TMOS34 -0.20%74 EV-to-FCF is 32.79 as of Jun. 27, 2026, which is 0% below its 10-year median of 32.91. GuruFocus rates BSP:TMOS34 with a GF Score™ of 74/100 and a GF Value™ of R$62.34 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 98 Medical Diagnostics & Research companies, Thermo Fisher Scientific ranks worse than 63.27% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Thermo Fisher Scientific's Enterprise Value is R$1,198,889 Mil.
Thermo Fisher Scientific's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was R$36,560 Mil. Therefore, Thermo Fisher Scientific's EV-to-FCF for today is 32.79.
The historical rank and industry rank for Thermo Fisher Scientific's EV-to-FCF or its related term are showing as below:
BSP:TMOS34'
s EV-to-FCF Range Over the Past 10 Years
Min: 23.72 Med: 32.91 Max: 46.34
Current: 34.19
During the past 13 years, the highest EV-to-FCF of Thermo Fisher Scientific was 46.34. The lowest was 23.72. And the median was 32.91.
BSP:TMOS34's EV-to-FCF is ranked worse than 63.27% of 98
companies
in the Medical Diagnostics & Research industry
Industry Median: 22.585
vs BSP:TMOS34: 34.19
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Thermo Fisher Scientific's PE Ratio (TTM) for today is calculated as:
Thermo Fisher Scientific's share price for today is R$54.84.
Thermo Fisher Scientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$2.047.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Thermo Fisher Scientific EV-to-FCF Related Terms
Thermo Fisher Scientific EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Thermo Fisher Scientific's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Thermo Fisher Scientific EV-to-FCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Thermo Fisher Scientific's EV-to-FCF falls into.
Thermo Fisher Scientific's current Enterprise Value is R$1,198,889 Mil.
Thermo Fisher Scientific's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$36,560 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thermo Fisher Scientific (BSP:TMOS34) has a EV-to-FCF of 32.79 as of Jun. 27, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Thermo Fisher Scientific and its competitors. This is near median its historical median of 32.91. Over the past decade, Thermo Fisher Scientific's EV-to-FCF has ranged from 23.72 to 46.34. According to the industry distribution chart, Thermo Fisher Scientific ranks #62 out of 98 companies in the Medical Diagnostics & Research industry, placing it in the top 63.3%.
Is Thermo Fisher Scientific's EV-to-FCF too high?
Thermo Fisher Scientific's current EV-to-FCF of 32.79 is near median its 10-year median of 32.91. Over the past 10 years, this metric has ranged from a low of 23.72 to a high of 46.34. The Medical Diagnostics & Research industry median EV-to-FCF is 22.59. Thermo Fisher Scientific's value of 32.79 is 45.2% above this industry median. Based on the distribution chart, Thermo Fisher Scientific ranks #62 out of 98 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Thermo Fisher Scientific has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Thermo Fisher Scientific's EV-to-FCF compare to DHR and IDXX?
According to the Medical Diagnostics & Research industry distribution chart, Thermo Fisher Scientific ranks #62 out of 98 companies for EV-to-FCF. This places Thermo Fisher Scientific in the lower half of its industry. The industry median EV-to-FCF is 22.59. Thermo Fisher Scientific's value of 32.79 is 45.2% above this benchmark. Historically, Thermo Fisher Scientific's own EV-to-FCF has ranged from 23.72 to 46.34 over the past decade. While the company's 10-year median is 32.91 vs. the industry median of 22.59, Thermo Fisher Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Diagnostics & Research company?
The median EV-to-FCF among Medical Diagnostics & Research companies is 22.59, based on 98 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Thermo Fisher Scientific's current EV-to-FCF of 32.79 is 45.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Thermo Fisher Scientific and its competitors. For the Medical Diagnostics & Research industry, the median EV-to-FCF is 22.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Thermo Fisher Scientific's current EV-to-FCF is 32.79, which is near median its own 10-year median of 32.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thermo Fisher Scientific stock overvalued right now?
Based on GuruFocus' analysis, Thermo Fisher Scientific (BSP:TMOS34) is currently considered Modestly Undervalued. The stock's GF Value™ is R$62.34, compared to a current price of R$54.84 — trading 12% below its estimated fair value. The current EV-to-FCF is 32.79, which is near median its 10-year median of 32.91 and 45.2% above the Medical Diagnostics & Research industry median of 22.59. Thermo Fisher Scientific's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Thermo Fisher Scientific (BSP:TMOS34), the current EV-to-FCF is 32.79 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Thermo Fisher Scientific (BSP:TMOS34) Overvalued in 2026?
Based on GuruFocus' analysis, Thermo Fisher Scientific stock appears to be undervalued.
The current stock price of R$54.84 is trading 12% below its estimated GF Value™ of R$62.34.
GuruFocus considers Thermo Fisher Scientific to be Modestly Undervalued.
Key valuation signals for BSP:TMOS34:
EV-to-FCF: 32.79 (near median its 10-year median of 32.91)
GF Value™: R$62.34 vs. price of R$54.84 (12% below fair value)
Industry Position: 45.2% above the Medical Diagnostics & Research median (#62 of 98)
No single metric tells the full story. See the BSP:TMOS34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
74GF Score
Get the complete analysis for BSP:TMOS34
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:TMOS34 has been successfully added to your 
